Effectiveness of Instrument-Assisted Soft Tissue Mobilization (IASTM) and Myofascial Release in Reducing Delayed Onset Muscle Soreness (DOMS) in the Cervicothoracic Region (COMPARE-DOMS)
To Compare the Effectiveness of Instrument Assisted Soft Tissue Mobilisation ( IASTM ) and Myofascial Release to Reducing Delayed Onset Muscle Soreness ( DOMS ) on Cervicothoracic Region
調査の概要
詳細な説明
Delayed onset muscle soreness (DOMS) is a physiological condition that develops in the course of time after strenuous unaccustomed physical exertion. In particular, DOMS occurs mostly in response to eccentric muscle actions, i.e., when muscle fibers lengthen while still performing work. Examples of eccentric actions may be, among others, lowering the load (weight training), downhill running, decelerating movements, and controlled return phase of resistance exercise (1). Unlike most types of physiological phenomena, DOMS usually develops after some period of time. Typically, it appears 12-24 hours after the workout and reaches its peak in 24-72 hours; afterwards, it will subside gradually over several days. DOMS is considered a normal adaptation reaction of the muscle. However, despite being physiologically beneficial and helping to adapt skeletal muscles to subsequent exercises through repeated bout phenomenon, DOMS may lead to considerable discomfort and even affect a person's quality of life. As the result of damage of muscle fibers and adjacent connective tissue in response to unaccustomed mechanical load, inflammatory reaction, swelling, and stimulation of pain receptors occurs. These processes are responsible for characteristic soreness associated with DOMS, which may impair individual's ability to perform certain activities and exercise.
The randomization process took place after participants were screened and underwent baseline assessment. Then, those who met the criteria were randomly allocated to Group A and Group B. Those patients in Group A were assigned to receive Instrument Assisted Soft Tissue Mobilization, whereas those participants who belonged to Group B were subjected to Myofascial Release. Random allocation was performed by a computer and carried out through opaque sealed envelopes opened by an independent individual.
研究の種類
入学 (実際)
段階
- 適用できない
連絡先と場所
研究場所
-
-
Sheikhupura
-
Lahore、Sheikhupura、パキスタン
- Green International University
-
-
参加基準
適格基準
就学可能な年齢
- 大人
健康ボランティアの受け入れ
説明
Inclusion Criteria:
- Participants aged between 30 and 40 years.
- Individuals presenting with delayed onset muscle soreness (DOMS) in the cervicothoracic region.
- Willingness to participate in either the IASTM or myofascial release intervention protocols.
- Ability to understand and sign the informed consent form.
Exclusion Criteria:
- History of recent cervical or thoracic spine surgery, fractures, or severe trauma in the region.
- Presence of open wounds, active skin infections, or severe dermatological conditions in the cervicothoracic area where interventions will be applied.
- Diagnosed neurological deficits, cervical radiculopathy, or myelopathy.
- Known contraindications to soft tissue mobilization or manual therapy (e.g., severe osteoporosis, bleeding disorders, or anticoagulant use).
- Current use of muscle relaxants, heavy analgesics, or NSAIDs that could mask DOMS symptoms during the study period.
研究計画
研究はどのように設計されていますか？
デザインの詳細
- 主な目的：処理
- 割り当て：ランダム化
- 介入モデル：並列代入
- マスキング：トリプル
武器と介入
参加者グループ / アーム |
介入・治療 |
|---|---|
|
実験的：IASTM
Instrument-Assisted Soft Tissue Mobilization (IASTM) is a type of therapy where the practitioner utilizes unique instruments that are made of either metals or hard plastics that have smooth curved surfaces to glide on the skin surface to work on soft tissues.
IASTM helps in identifying and breaking down areas of muscle tightness and adhesion.
Blood flow is stimulated, pain, stiffness, and soreness are minimized, and mobility of the tissues is enhanced, thereby increasing joint range of motion.
|
The participants in this group were given the Instrument Assisted Soft Tissue Mobilization (IASTM).
They were rubbed with a very small amount of gel or lotion to allow easy mobilization of the tool over the skin.
The instrument has been developed to treat conditions of the cervical-thoracic joint region.
The instrument was applied over the upper trapezius muscle and the cervicothoracic joint region using controlled unidirectional strokes for 8-10 minutes each day with moderate pressure.
The process was done once every day for 2-3 days after the occurrence of Delayed Onset Muscle Soreness
Group B: Myofascial Release Those who fell under Group B were subjected to myofascial release.
The physiotherapist used hands to apply slow and gentle pressure on the tissues that needed release.
Fascia and muscles of the upper trapezius, levator scapulae, and cervicothoracic paraspinal muscles were applied pressure on until there was release of the
|
|
アクティブコンパレータ：Myofascial Release
Myofascial Release (MFR) is an effective therapeutic massage technique that can be utilized to relieve muscle and fascia pain and tightness.
The practitioner uses a series of gentle stretching or applying sustained pressure on areas where tension is felt until the fascia releases.
Such release eases pain, improves circulation, joint mobility and muscle motion, enhances flexibility and posture
|
The participants in this group were given the Instrument Assisted Soft Tissue Mobilization (IASTM).
They were rubbed with a very small amount of gel or lotion to allow easy mobilization of the tool over the skin.
The instrument has been developed to treat conditions of the cervical-thoracic joint region.
The instrument was applied over the upper trapezius muscle and the cervicothoracic joint region using controlled unidirectional strokes for 8-10 minutes each day with moderate pressure.
The process was done once every day for 2-3 days after the occurrence of Delayed Onset Muscle Soreness
Group B: Myofascial Release Those who fell under Group B were subjected to myofascial release.
The physiotherapist used hands to apply slow and gentle pressure on the tissues that needed release.
Fascia and muscles of the upper trapezius, levator scapulae, and cervicothoracic paraspinal muscles were applied pressure on until there was release of the
|
この研究は何を測定していますか？
主要な結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
Visual Analog Scale (VAS) for pain
時間枠：Baseline (pre-induction), Post-DOMS induction (24 hours), 48 hours, and 72 hours.
|
The Visual Analog Scale (VAS) is a 100 mm continuous line used to self-report cervicothoracic pain intensity.
The scale ranges from 0 mm (indicating "no pain") to 100 mm (indicating "worst imaginable pain").
Participants mark a point on the line that represents their current pain perception at rest and during active movement.
|
Baseline (pre-induction), Post-DOMS induction (24 hours), 48 hours, and 72 hours.
|
二次結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
Cervical Range of Motion (CROM)
時間枠：Baseline (pre-induction), Post-DOMS induction (24 hours), 48 hours, and 72 hours.
|
Active cervical range of motion will be measured in degrees using a digital inclinometer or a cervical range of motion instrument.
Movement planes will include cervical flexion, extension, lateral flexion (left and right), and rotation (left and right).
Decreased ranges indicate higher functional restriction due to muscle soreness.
|
Baseline (pre-induction), Post-DOMS induction (24 hours), 48 hours, and 72 hours.
|
|
Pressure Pain Threshold (PPT)
時間枠：Baseline (pre-induction), Post-DOMS induction (24 hours), 48 hours, and 72 hours.
|
Pressure pain threshold will be measured in kilograms per square centimeter (kg/cm²) using a digital hand-held pressure algometer applied over standardized trigger points in the upper trapezius and levator scapulae muscles.
PPT determines the minimum pressure at which a sensation of pressure changes to pain.
|
Baseline (pre-induction), Post-DOMS induction (24 hours), 48 hours, and 72 hours.
|
協力者と研究者
捜査官
- 主任研究者：Iqra Majeed Principal Investigator、Green International University, Lahore, Punjab
研究記録日
主要日程の研究
研究開始 (実際)
一次修了 (実際)
研究の完了 (実際)
試験登録日
最初に提出
QC基準を満たした最初の提出物
最初の投稿 (実際)
学習記録の更新
投稿された最後の更新 (実際)
QC基準を満たした最後の更新が送信されました
最終確認日
詳しくは
本研究に関する用語
キーワード
その他の研究ID番号
- GIU/REC/26-25
個々の参加者データ (IPD) の計画
個々の参加者データ (IPD) を共有する予定はありますか?
IPD プランの説明
IPD 共有時間枠
IPD 共有アクセス基準
IPD 共有サポート情報タイプ
- STUDY_PROTOCOL
- SAP
- ICF
- CSR
医薬品およびデバイス情報、研究文書
米国FDA規制医薬品の研究
米国FDA規制機器製品の研究
この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。